Evotec SE (ETR:EVT)
5.18
-0.09 (-1.61%)
May 8, 2026, 5:35 PM CET
Evotec SE Employees
Evotec SE had 4,467 employees as of December 31, 2025. The number of employees decreased by 273 or -5.76% compared to the previous year.
Employees
4,467
Change
-273
Growth
-5.76%
Revenue / Employee
€176,488
Profits / Employee
€23,174
Market Cap
920.74M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4,467 | -273 | -5.76% |
| Sep 30, 2025 | 4,788 | -219 | -4.37% |
| Jun 30, 2025 | 4,759 | -263 | -5.24% |
| Mar 31, 2025 | 4,766 | -289 | -5.72% |
| Dec 31, 2024 | 4,740 | -321 | -6.34% |
| Sep 30, 2024 | 5,007 | -79 | -1.55% |
| Jun 30, 2024 | 5,022 | -45 | -0.89% |
| Mar 31, 2024 | 5,055 | 103 | 2.08% |
| Dec 31, 2023 | 5,061 | 109 | 2.20% |
| Sep 30, 2023 | 5,086 | 371 | 7.87% |
| Jun 30, 2023 | 5,067 | 546 | 12.08% |
| Dec 31, 2022 | 4,952 | 754 | 17.96% |
| Sep 30, 2022 | 4,715 | 634 | 15.54% |
| Jun 30, 2022 | 4,521 | 607 | 15.51% |
| Mar 31, 2022 | 4,354 | 619 | 16.57% |
| Dec 31, 2021 | 4,198 | 626 | 17.53% |
| Sep 30, 2021 | 4,081 | 637 | 18.50% |
| Jun 30, 2021 | 3,914 | 636 | 19.40% |
| Mar 31, 2021 | 3,735 | 705 | 23.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 178,583 |
| Bayer Aktiengesellschaft | 87,280 |
| Siemens Healthineers AG | 73,800 |
| Merck KGaA | 59,077 |
| Drägerwerk AG & Co. KGaA | 16,033 |
| RHÖN-KLINIKUM Aktiengesellschaft | 14,144 |
| Gerresheimer AG | 13,535 |
| SCHOTT Pharma AG & Co. KGaA | 4,829 |
Evotec SE News
- 2 days ago - Q1 2026 Evotec SE Earnings Call Transcript - GuruFocus
- 4 days ago - EQS-DD: Evotec SE: Paul Hitchin, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system. - Wallstreet:Online
- 4 days ago - EQS-DD: Evotec SE: Aurélie Dalbiez, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system. - Wallstreet:Online
- 4 days ago - EQS-DD: Evotec SE: Dr. Christian Wojczewski, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system. - Wallstreet:Online
- 4 days ago - EQS-DD: Evotec SE: Dr. Cord Dohrmann, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system. - Wallstreet:Online
- 4 days ago - EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 5 days ago - Evotec (EVO) Advances Preclinical Development Candidate in Dermatology - GuruFocus
- 5 days ago - Evotec nominates first preclinical development candidate from Almirall pact - TheFly